Latest debt-to-equity ratio
Nurix Therapeutics Debt-to-equity ratio
Direct answer
Nurix Therapeutics's debt-to-equity ratio is 14.44%.
The verified market snapshot reports 14.44%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 22, 2026.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 14.44%
Explore related company data
View Nurix Therapeutics's market capitalizationView Nurix Therapeutics's price-to-book ratioView Nurix Therapeutics's return on equityView Nurix Therapeutics's 52-week price rangeView Nurix Therapeutics's revenue growthView Nurix Therapeutics's profit marginView all Nurix Therapeutics key metricsReturn to Nurix Therapeutics profile